Ninety One (UK)
WST icon

Ninety One (UK)’s West Pharmaceutical WST Stock Holding History

Ninety One (UK)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4M Sell
93,032
-26,199
-22% -$8.01M 0.07% 133
2026
Q1 		$29.9M Buy
119,231
+17,343
+17% +$4.32M 0.07% 121
2025
Q4 		$28M Buy
101,888
+3,970
+4% +$1.09M 0.06% 119
2025
Q3 		$25.7M Sell
97,918
-2,707
-3% -$658K 0.06% 126
2025
Q2 		$22M Sell
100,625
-11,885
-11% -$2.54M 0.05% 126
2025
Q1 		$25.2M Buy
112,510
+28,235
+34% +$7.78M 0.07% 126
2024
Q4 		$27.6M Sell
84,275
-3,623
-4% -$1.14M 0.07% 123
2024
Q3 		$26.4M Buy
87,898
+55,372
+170% +$17M 0.07% 121
2024
Q2 		$10.7M Sell
32,526
-1,800
-5% -$636K 0.03% 151
2024
Q1 		$13.6M Hold
34,326
– – 0.04% 149
2023
Q4 		$12.1M Buy
34,326
+6,143
+22% +$2.17M 0.04% 147
2023
Q3 		$10.6M Hold
28,183
– – 0.03% 148
2023
Q2 		$10.8M Sell
28,183
-285
-1% -$102K 0.03% 152
2023
Q1 		$9.86M Buy
+28,468
New +$8.32M 0.03% 156

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ninety One (UK)'s WST Position: Q2 2026 in Review

Ninety One (UK) reduced its West Pharmaceutical (WST) stake by 22% in Q2 2026, selling an estimated $8.01M and leaving 93,032 shares worth $33.4M. The position accounts for 0.07% of the portfolio, ranked #133.

Ninety One (UK) first reported a position in WST in Q1 2023 and has held it in 14 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Ninety One (UK) held 93,032 shares of West Pharmaceutical worth $33.4M as of Q2 2026.
  • Ninety One (UK) sold 26,199 West Pharmaceutical shares in Q2 2026, an estimated $8.01M.
  • West Pharmaceutical made up 0.07% of Ninety One (UK)'s portfolio in Q2 2026, its #133 holding.
  • Ninety One (UK) first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.